D. Rivollet

626 total citations
17 papers, 523 citations indexed

About

D. Rivollet is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Organic Chemistry. According to data from OpenAlex, D. Rivollet has authored 17 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 9 papers in Epidemiology and 3 papers in Organic Chemistry. Recurrent topics in D. Rivollet's work include Research on Leishmaniasis Studies (15 papers), Trypanosoma species research and implications (9 papers) and Synthesis and Biological Evaluation (3 papers). D. Rivollet is often cited by papers focused on Research on Leishmaniasis Studies (15 papers), Trypanosoma species research and implications (9 papers) and Synthesis and Biological Evaluation (3 papers). D. Rivollet collaborates with scholars based in France, Czechia and United States. D. Rivollet's co-authors include M Deniau, Muriel Paul, A. Astier, Rémy Durand, R. Houin, Stéphane Bretagne, Michèle Deniau, Françoise Botterel, Hatem Fessi and Michel Vidaud and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and International Journal for Parasitology.

In The Last Decade

D. Rivollet

17 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Rivollet France 15 372 265 80 77 69 17 523
Paulo C. Cotrim Brazil 15 418 1.1× 354 1.3× 35 0.4× 97 1.3× 90 1.3× 32 567
Maryam Hakimi Parizi Iran 16 529 1.4× 189 0.7× 110 1.4× 106 1.4× 42 0.6× 36 650
Eduardo Fonseca Pinto Brazil 13 312 0.8× 209 0.8× 44 0.6× 69 0.9× 33 0.5× 21 459
Fernanda Ludolf Brazil 17 327 0.9× 227 0.9× 42 0.5× 145 1.9× 92 1.3× 36 545
Mahshid Mostafavi Iran 15 319 0.9× 127 0.5× 29 0.4× 47 0.6× 52 0.8× 31 411
Pramod Kumar Kushawaha India 12 341 0.9× 251 0.9× 48 0.6× 75 1.0× 67 1.0× 26 502
Julieta Ruiz-Esmenjaud Mexico 4 636 1.7× 364 1.4× 78 1.0× 125 1.6× 115 1.7× 5 770
Edoardo Torres‐Guerrero Mexico 5 635 1.7× 422 1.6× 88 1.1× 122 1.6× 115 1.7× 11 817
Katrien Van Bocxlaer United Kingdom 15 483 1.3× 246 0.9× 27 0.3× 59 0.8× 162 2.3× 23 603

Countries citing papers authored by D. Rivollet

Since Specialization
Citations

This map shows the geographic impact of D. Rivollet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Rivollet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Rivollet more than expected).

Fields of papers citing papers by D. Rivollet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Rivollet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Rivollet. The network helps show where D. Rivollet may publish in the future.

Co-authorship network of co-authors of D. Rivollet

This figure shows the co-authorship network connecting the top 25 collaborators of D. Rivollet. A scholar is included among the top collaborators of D. Rivollet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Rivollet. D. Rivollet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Khoufache, Khaled, Odile Cabaret, D. Rivollet, et al.. (2010). Primaryin vitroculture of porcine tracheal epithelial cells in an air-liquid interface as a model to study airway epithelium andAspergillus fumigatusinteractions. Medical Mycology. 48(8). 1049–1055. 22 indexed citations
2.
Bellanger, Anne‐Pauline, Laurence Millon, Khaled Khoufache, et al.. (2009). Aspergillus fumigatus germ tube growth and not conidia ingestion induces expression of inflammatory mediator genes in the human lung epithelial cell line A549. Journal of Medical Microbiology. 58(2). 174–179. 58 indexed citations
3.
Foulet, F., Françoise Botterel, Pierre Buffet, et al.. (2007). Detection and Identification ofLeishmaniaSpecies from Clinical Specimens by Using a Real-Time PCR Assay and Sequencing of the CytochromebGene. Journal of Clinical Microbiology. 45(7). 2110–2115. 81 indexed citations
4.
Paul, Muriel, et al.. (2003). Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis. Annals of Tropical Medicine and Parasitology. 97(3). 259–268. 17 indexed citations
5.
Loiseau, Philippe M., Julia S. Lehman, D. Rivollet, et al.. (2002). Characterisation of atovaquone resistance in Leishmania infantum promastigotes. International Journal for Parasitology. 32(8). 1043–1051. 24 indexed citations
6.
Paul, Muriel, et al.. (2000). Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis. International Journal for Parasitology. 30(6). 777–783. 34 indexed citations
7.
Périanin, Axel, et al.. (2000). Sodium Stibogluconate (Pentostam) Potentiates Oxidant Production in Murine Visceral Leishmaniasis and in Human Blood. Antimicrobial Agents and Chemotherapy. 44(9). 2406–2410. 39 indexed citations
8.
Paul, Muriel, Rémy Durand, Yves Boulard, et al.. (1998). Physicochemical Characteristics of Pentamidine-Loaded Polymethacrylate Nanoparticles: Implication in the Intracellular Drug Release inLeishmania MajorInfected Mice. Journal of drug targeting. 5(6). 481–490. 40 indexed citations
9.
Durand, Rémy, Muriel Paul, Francine Pratlong, et al.. (1998). Leishmania infantum : Lack of Parasite Resistance to Amphotericin B in a Clinically Resistant Visceral Leishmaniasis. Antimicrobial Agents and Chemotherapy. 42(8). 2141–2143. 30 indexed citations
10.
11.
Durand, Rémy, Muriel Paul, D. Rivollet, et al.. (1997). Activity of pentamidine-loaded poly (D, L-lactide) nanoparticles againstLeishmania infantumin a murine model. Parasite. 4(4). 331–336. 23 indexed citations
12.
Fusaı̈, Thierry, Yves Boulard, Rémy Durand, et al.. (1997). Ultrastructural changes in parasites induced by nanoparticle-bound pentamidine in aLeishmania major/mouse model. Parasite. 4(2). 133–139. 19 indexed citations
13.
Paul, Muriel, Rémy Durand, Hatem Fessi, et al.. (1997). Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrobial Agents and Chemotherapy. 41(8). 1731–1734. 28 indexed citations
14.
Costa, J.‐M., Rémy Durand, M Deniau, et al.. (1996). PCR enzyme-linked immunosorbent assay for diagnosis of leishmaniasis in human immunodeficiency virus-infected patients. Journal of Clinical Microbiology. 34(7). 1831–1833. 53 indexed citations
15.
Deniau, M, et al.. (1996). Leishmaniasis in AIDS patients: results of leukocytoconcentration, a fast biological method of diagnosis.. PubMed. 74(1). 91–3. 22 indexed citations
16.
Fusaı̈, Thierry, Rémy Durand, Yves Boulard, et al.. (1995). [Importance of drug carriers in the treatment of visceral leishmaniasis].. PubMed. 55(1). 73–8. 7 indexed citations
17.
Fusaı̈, Thierry, M Deniau, Rémy Durand, et al.. (1994). Action of pentamidine-bound nanoparticles againstLeishmaniaon anin vivomodel. Parasite. 1(4). 319–324. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026